Parkinsons and Huntington Dementia
Parkinson's dementia is characterized by cognitive decline in memory, executive function, and visuospatial abilities. The presence of dementia in Parkinson's disease is associated with a more rapid disease progression and increased mortality. Research is focusing on identifying biomarkers for early detection of Parkinson's dementia and developing targeted therapies to prevent or slow cognitive decline.
Huntington's dementia is characterized by cognitive decline in executive function, language, and behavior. The presence of dementia in Huntington's disease is associated with a more severe motor phenotype and increased disability. Research is focusing on understanding the role of the huntingtin protein in cognitive decline and developing neuroprotective therapies to slow the progression of Huntington's dementia.
The Alzheimer's 2024 conference promises to be a significant event in the field of neurodegenerative dementia research, offering new insights and hope for improved diagnosis, treatment, and prevention of Parkinson's and Huntington's dementia.